Effect of diet therapy in treatment of polycystic ovary syndrome

Effects of the hypocaloric DASH diet on metabolic parameters, inflammatory factor and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201304235623N6

Enrollment

108

Registered

2013-05-04

Start date

2013-04-23

Completion date

Unknown

Last updated

2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovary syndrome. Sclerocystic ovary syndrome Stein-Leventhal syndrome

Interventions

Intervention 1: Control group: Standard diet designed based on calorie-restricted (500 kcal), 3 serving vegetables, 3 serving fruits, rich in protein, daily for 8 weeks. Intervention 2: Intervention g

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Women aged 18-40 years Diagnosed with PCOS

Exclusion criteria

Exclusion criteria: Individuals with neoplastic Cardiovascular disorders Malabsorptive disorders Current or previous (within the last 6 months) use of hormonal Antidiabetic medications Anti-obesity medications

Design outcomes

Primary

Measure	Time frame
LDL-Cholesterol. Timepoint: Baseline and End-of-trial. Method of measurement: Enzymatic.;Hs-CRP. Timepoint: Baseline and End-of-trial. Method of measurement: Elisa.	—

Secondary

Measure	Time frame
Triglycerides. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Enzymatic kit.;HDL-cholesterol. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Enzymatic kit.;Insulin. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Elisa kit.;Insulin resistance. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Calculation using HOMA formula.;Total antioxidant capacity. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Spectrophotometry.;. Timepoint: . Method of measurement: .;Glutathione. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Spectrophotometry.	—

Measure

Time frame

Triglycerides. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Enzymatic kit.;HDL-cholesterol. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Enzymatic kit.;Insulin. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Elisa kit.;Insulin resistance. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Calculation using HOMA formula.;Total antioxidant capacity. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Spectrophotometry.;. Timepoint: . Method of measurement: .;Glutathione. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Spectrophotometry.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZatollah Asemi

Kashan University of Medical Sciences

asemi_r@yahoo.com+98 31 5546 3378

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Mar 7, 2026